RecruitingNCT07196501

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This recruiting study focuses on depression and currently lists sites or participation links in Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States.

DepressionOtherOver 18 Years

In plain English

Key information made simple

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability. For people living with Depression, small gains in stability can make a meaningful difference over time. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Neurocrine Clinical Site in Oceanside, Neurocrine Clinical Site in San Jose, and Neurocrine Clinical Site in New Haven. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and having a stable enough treatment background for the study, while common reasons not to take part include safety concerns that need urgent care first and other treatments that could interfere with the study. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT07196501. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Australia.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com